- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06294704
Hybrid Closed Loop Insulin Pump and Bariatric Surgery in Patients With Type 1 Diabetes (PompBariatDT1)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients with type 1 diabetes and obesity are at risk of "double diabetes". Bariatric surgery may be indicated for these patients, to combat insulin resistance. Nevertheless, post-operative patients are at risk of hypoglycemia.
At the same time, patients with type 1 diabetes can benefit from a hybrid closed loop insulin pump to improve diabetes control and reduce the occurrence of hypoglycemia.
In type 1 diabetic patients who have undergone bariatric surgery and are treated with a hybrid closed loop insulin pump, continuous glucose measurement can be studied. In the medium and long term, the efficacy and safety of this system in this context will be described.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Caroline TOURTE
- Phone Number: +33161693150
- Email: caroline.tourte@chsf.fr
Study Contact Backup
- Name: Geoffrey BOULATE, MD
- Phone Number: 01.61.69.75.85
- Email: geoffrey.boulate@chsf.fr
Study Locations
-
-
-
Corbeil-Essonnes, France, 91106
- Centre Hospitalier Sud Francilien
-
Contact:
- Caroline TOURTE
- Phone Number: +33161693150
- Email: caroline.tourte@chsf.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Major patient
- With type 1 diabetes for > 1 year
- Obese (BMI≥30)
- Having undergone bariatric surgery
- On a hybrid closed-loop insulin pump
- Not pregnant
- No hybrid closed-loop insulin pump discontinuation for more than 45 days after surgery
Exclusion Criteria:
- Patient informed and opposed to data use
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
time spent within glycemic target 70-180 mg/dL
Time Frame: at 3 months
|
time spent within glycemic target 70-180 mg/dL in type 1 diabetes patients who underwent bariatric surgery,
|
at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time spent in level 1 hyperglycemia (181-250 mg/dL)
Time Frame: at 3 months
|
Time spent in level 1 hyperglycemia (181-250 mg/dL) Time spent in level 1 hyperglycemia (181-250 mg/dL) Time spent in level 1 hyperglycemia (181-250 mg/dL) |
at 3 months
|
Time spent in level 2 hyperglycemia (>250 mg/dL)
Time Frame: at 3 months
|
Time spent in level 2 hyperglycemia (>250 mg/dL)
|
at 3 months
|
HbA1c
Time Frame: at 3 months
|
HbA1c
|
at 3 months
|
Coefficient of variation
Time Frame: at 3 months
|
Coefficient of variation
|
at 3 months
|
Time spent in level 1 hypoglycemia (51-70 mg/dl)
Time Frame: at 3 months
|
Time spent in level 1 hypoglycemia (51-70 mg/dl)
|
at 3 months
|
Time spent in level 2 hypoglycemia (< 50 mg/gdl)
Time Frame: at 3 months
|
Time spent in level 2 hypoglycemia (< 50 mg/gdl)
|
at 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Geoffrey BOULATE, MD, Centre Hospitalier Sud Francilien
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/0004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on bariatric surgery
-
Centre Hospitalier Universitaire de NiceTerminatedObesity | Chronic Kidney DiseaseFrance
-
Imperial College LondonRecruitingObesity | Type 2 DiabetesIreland
-
McMaster UniversityNot yet recruitingRobotic Surgery | Bariatric Surgery
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI); National Institute of Diabetes and Digestive...RecruitingCardiovascular Diseases | Hypertension | Dyslipidemias | Type 2 Diabetes | Morbid Obesity | Bariatric Surgery CandidateUnited States
-
Guy's and St Thomas' NHS Foundation TrustRecruitingObesity Hypoventilation Syndrome (OHS)United Kingdom
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Rabin Medical CenterRecruiting
-
V.K.V. American Hospital, IstanbulCompletedBariatric Surgery Candidate | Post Operative Pain | Regional Anesthesia MorbidityTurkey
-
Hacettepe UniversityCompleted